Cargando…
Ma Xing Shi Gan Decoction Attenuates PM2.5 Induced Lung Injury via Inhibiting HMGB1/TLR4/NFκB Signal Pathway in Rat
Ma Xing Shi Gan Decoction (MXD), a classical traditional Chinese medicine prescription, is widely used for the treatment of upper respiratory tract infection. However, the effect of MXD against particulate matters with diameter of less than 2.5 μm (PM2.5) induced lung injury remains to be elucidated...
Autores principales: | Fei, Yu-xiang, Zhao, Bo, Yin, Qi-yang, Qiu, Yan-ying, Ren, Guang-hui, Wang, Bo-wen, Wang, Ye-fang, Fang, Wei-rong, Li, Yun-man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868102/ https://www.ncbi.nlm.nih.gov/pubmed/31798456 http://dx.doi.org/10.3389/fphar.2019.01361 |
Ejemplares similares
-
Ma Xing Shi Gan Decoction Protects against PM2.5-Induced Lung Injury through Suppression of Epithelial-to-Mesenchymal Transition (EMT) and Epithelial Barrier Disruption
por: Wang, Ye-fang, et al.
Publicado: (2020) -
Systematic Pharmacological Strategies to Explore the Regulatory Mechanism of Ma Xing Shi Gan Decoction on COVID-19()
por: Shi-Ying, Zhang, et al.
Publicado: (2020) -
Ma xing shi gan decoction eliminates PM2.5-induced lung injury by reducing pulmonary cell apoptosis through Akt/mTOR/p70S6K pathway in rats
por: Wang, Yefang, et al.
Publicado: (2020) -
Antitussive, anti-pyretic and toxicological evaluation of Ma-Xing-Gan-Shi-Tang in rodents
por: Lin, Yu-Chin, et al.
Publicado: (2016) -
Deciphering the Pharmacological Mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through Integrating Network Pharmacology and Experimental Exploration
por: Li, Qianqian, et al.
Publicado: (2020)